A randomized open-label, multinational, multicentre, phase III clinical study to evaluate the efficacy and safety of Ibuprofen oral suspension 20 mg/ml and Ibuprofen oral suspension 40 mg/ml (Berlin-Chemie) compared with Nurofen oral suspension 20 mg/ml (Reckitt Benckiser) in children 3-9 years old with uncomplicated acute otitis media

Trial Profile

A randomized open-label, multinational, multicentre, phase III clinical study to evaluate the efficacy and safety of Ibuprofen oral suspension 20 mg/ml and Ibuprofen oral suspension 40 mg/ml (Berlin-Chemie) compared with Nurofen oral suspension 20 mg/ml (Reckitt Benckiser) in children 3-9 years old with uncomplicated acute otitis media

Recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Mar 2016

At a glance

  • Drugs Ibuprofen (Primary)
  • Indications Otitis media
  • Focus Therapeutic Use
  • Sponsors Berlin Chemie
  • Most Recent Events

    • 08 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top